Get the Stockscreener App
1.255
2.87%
0.035
Ernexa Therapeutics Inc stock is traded at $1.255, with a volume of 54,066.
It is up +2.87% in the last 24 hours and down -25.74% over the past month.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
See More
Previous Close:
$1.22
Open:
$1.23
24h Volume:
54,066
Relative Volume:
0.68
Market Cap:
$9.63M
Revenue:
$598.00K
Net Income/Loss:
$-44.93M
P/E Ratio:
-0.151
EPS:
-8.31
Net Cash Flow:
$-17.32M
1W Performance:
-5.64%
1M Performance:
-25.74%
6M Performance:
-70.64%
1Y Performance:
-95.02%
1-Day Range:
$1.21
$1.29
1-Week Range:
$1.21
$1.4665
52-Week Range:
$1.21
$24.30
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
Name
Ernexa Therapeutics Inc
Sector
Industry
Phone
(617) 798-6700
Address
1035 CAMBRIDGE STREET, CAMBRIDGE
Compare ERNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.255 | 9.36M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Ernexa Therapeutics Inc Stock (ERNA) Latest News
Heatmap analysis for Ernexa Therapeutics Inc. and competitors2025 Bull vs Bear & Verified Entry Point Detection - Newser
Using data tools to time your Ernexa Therapeutics Inc. exitOil Prices & Free Technical Confirmation Trade Alerts - Newser
Using fundamentals and technicals on Ernexa Therapeutics Inc.Weekly Market Outlook & Entry Point Confirmation Signals - Newser
Volume spikes in Ernexa Therapeutics Inc. stock – what they meanJuly 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
Exit strategy if you’re trapped in Ernexa Therapeutics Inc.Risk Management & Advanced Technical Signal Analysis - Newser
Ernexa Therapeutics Inc. stock trend forecastWeekly Trade Review & Free Technical Confirmation Trade Alerts - Newser
Price action breakdown for Ernexa Therapeutics Inc.2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
Should you hold or exit Ernexa Therapeutics Inc. nowQuarterly Market Review & Step-by-Step Trade Execution Guides - Newser
Can Ernexa Therapeutics Inc. deliver alphaJuly 2025 Pullbacks & Low Risk Entry Point Tips - خودرو بانک
Is Ernexa Therapeutics Inc. stock forming a triangle patternQuarterly Trade Report & Free Weekly Watchlist of Top Performers - خودرو بانک
Is Ernexa Therapeutics Inc. in a long term uptrendInsider Buying & Accurate Buy Signal Alerts - خودرو بانک
Evaluating Ernexa Therapeutics Inc. with trendline analysisWeekly Investment Report & Safe Entry Point Identification - Newser
Is Ernexa Therapeutics Inc. a speculative investmentMarket Growth Report & Low Drawdown Trading Strategies - خودرو بانک
How is Ernexa Therapeutics Inc. managing supply chain issuesJuly 2025 Reactions & Verified Entry Point Detection - 시사인 투데이
How to integrate Ernexa Therapeutics Inc. into portfolio analysis toolsQuarterly Market Summary & Weekly Stock Breakout Alerts - Newser
Is Ernexa Therapeutics Inc. gaining market share2025 Analyst Calls & Accurate Entry and Exit Point Alerts - خودرو بانک
Does Ernexa Therapeutics Inc. fit your quant trading modelJuly 2025 Final Week & Risk Adjusted Buy and Sell Alerts - Newser
Long term hold vs stop loss in Ernexa Therapeutics Inc.Trade Signal Summary & Expert Approved Momentum Ideas - Newser
What’s next for Ernexa Therapeutics Inc. stock price2025 Momentum Check & Fast Gain Stock Tips - Newser
What does recent volatility data suggest for Ernexa Therapeutics Inc.2025 Institutional Moves & Community Verified Swing Trade Signals - Newser
Has Ernexa Therapeutics Inc. found a price floor2025 Institutional Moves & Verified Swing Trading Watchlists - Newser
Is Ernexa Therapeutics Inc. impacted by rising ratesEarnings Growth Summary & Weekly Watchlist for Consistent Profits - خودرو بانک
Candlestick signals on Ernexa Therapeutics Inc. stock todayStop Loss & AI Driven Price Forecasts - Newser
Aug Gainers: Is Ernexa Therapeutics Inc.’s ROE strong enough2025 Earnings Impact & Weekly Chart Analysis and Guides - خودرو بانک
Will Ernexa Therapeutics Inc. see short term momentumTrade Entry Summary & Daily Entry Point Alerts - Newser
What is the earnings history of Ernexa Therapeutics Inc.July 2025 Macro Moves & Scalable Portfolio Growth Methods - خودرو بانک
Is Ernexa Therapeutics Inc. forming a bottoming baseMarket Growth Summary & Long-Term Safe Investment Ideas - Newser
Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Ernexa Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - Quiver Quantitative
Novel Off-the-Shelf Cell Therapy: Ernexa to Present Cancer Treatment Pipeline Advancing to Clinic 2026 - Stock Titan
What’s the recovery path for long term holders of Ernexa Therapeutics Inc.2025 Market Outlook & Smart Money Movement Tracker - Newser
How to interpret RSI for Ernexa Therapeutics Inc. stock2025 Price Targets & Smart Allocation Stock Reports - Newser
Ranking Ernexa Therapeutics Inc. among high performing stocks via toolsEarnings Trend Report & Advanced Swing Trade Entry Alerts - Newser
Will Ernexa Therapeutics Inc. stock recover after earningsShare Buyback & Smart Allocation Stock Tips - خودرو بانک
Published on: 2025-09-02 10:13:31 - Newser
Can swing trading help recover from Ernexa Therapeutics Inc. lossesSwing Trade & Advanced Technical Analysis Signals - Newser
Ernexa Therapeutics Inc Stock (ERNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):